Full Text
HSD19 Can Switching From Intravenous (IV) to Subcutaneous (SC) Formulations Save Time and Resources? A Service Impact Model (SIM)

Abstract

Authors

Stephen Bradley Oliver Mann

Back to Volume 28, Supplemental Issue 12S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×